Tiny study tests drug dosing in burn patients
NCT ID NCT00748345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the antifungal medicine caspofungin is processed in the bodies of adults with serious burns. The goal was to find the best dose, since burns can change how drugs work. Only 2 people took part, so the results are very limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BURN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cochin
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an enzyme gel dissolve burned tissue without surgery?
- Can a sugar pill curb the opioid crisis?
- Which burn score best predicts who will survive?
- AI learns to see burns on hands, head, and feet
- Border-Region study investigates whether nationality affects burn survival
- Water spray may help burn survivors beat the heat while working out